vislarafusp-alfa (IMM2902) - ImmuneOnco Biopharma
pumitamig (BNT327) - BioNTech, BMS
Bizengri (zenocutuzumab-zbco) - Partner Therap, Genmab
izuralimab (XmAb23104) - Xencor
Idafang (ivonescimab) - Summit Therapeutics
rilvegostomig (AZD2936) - AstraZeneca
NI-1801 - Light Chain Biosci
Ennituo (anbenitamab) - Alphamab
https://www.asco.org/abstracts-presentations/257969/
 
Trie Arni Djunadi; Falak Naz; Sai Sushrutha Mudupula Vemula; Sumbal Aziz; Woo Joo Lee; Zunairah Shah
 
Apr 21, 2026
 
Prev Next